Short-term adverse events following immunization with modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine for Mpox Read more about Short-term adverse events following immunization with modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine for Mpox19 views
Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia Read more about Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia4 views
Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: an Australian retrospective cohort study Read more about Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: an Australian retrospective cohort study29 views
Background rates of adverse events of special interest for COVID-19 vaccines: a multinational Global Vaccine Data Network (GVDN) analysis Read more about Background rates of adverse events of special interest for COVID-19 vaccines: a multinational Global Vaccine Data Network (GVDN) analysis53 views
Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines Read more about Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines45 views
“I’m scared that if I have the vaccine, it’s going to make my lung condition worse, not better.” COVID-19 vaccine acceptance in adults with underlying health conditions – a qualitative investigation Read more about “I’m scared that if I have the vaccine, it’s going to make my lung condition worse, not better.” COVID-19 vaccine acceptance in adults with underlying health conditions – a qualitative investigation26 views
Surveillance of adverse events following immunisation in Australia annual report, 2020 Read more about Surveillance of adverse events following immunisation in Australia annual report, 202022 views
Status epilepticus following vaccination in children aged ≤24 months: a five-year retrospective observational study Read more about Status epilepticus following vaccination in children aged ≤24 months: a five-year retrospective observational study19 views
Status epilepticus outcomes among vaccinated and unvaccinated children: a population-based study Read more about Status epilepticus outcomes among vaccinated and unvaccinated children: a population-based study27 views
Impact evaluation of Australian national HPV vaccination program Submitted by Anonymous on Fri, 26/02/2021 NCIRS evaluation of the impact of the national HPV vaccination program has found that HPV vaccination coverage is high and there has been a substantial reduction in the burden of HPV-related disease since the introduction of the vaccine in Australia. It was also found that adverse events following immunisation with HPV vaccine have been predominantly mild and transient in nature, with the vaccine safety record similar to that of other vaccines on the National Immunisation Program. Read more about Impact evaluation of Australian national HPV vaccination program335 views
